【导读】代谢组学和16S rDNA测序在阐明与疾病相关的复杂机制方面显示出巨大潜力。目前，有关胃癌的组学研究很少，而且缺乏有效的生物标志物。2025年1月6日，扬州大学医学院转化医学研究所Liu ...

Stomach cancer, also known as gastric cancer, is the growth of abnormal cells that form a mass in the stomach. Symptoms of ...

Now, China-based CARsgen has shared pivotal results from the latter portion of a phase 1/2 study evaluating the therapy for ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

A new electronic health record-based model accurately predicted risk for gastric cancer using demographic, behavioral and ...

A WOMAN is cancer-free after undergoing the UK’s first liver transplant for advanced bowel cancer. Bianca Perea, 32, was ...

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase III for Gastric Cancer. According to GlobalData, Phase III drugs for Gastric Cancer have a 46% phase transition ...

Retlirafusp alfa is under clinical development by Jiangsu Hengrui Medicine and currently in Phase III for Gastric Cancer.

Astellas Pharma Inc. (ALPMY, ALPMY) announced that China's National Medical Products Administration approved VYLOY (zolbetuximab), in ...

The FDA approved subcutaneous nivolumab for solid tumors, tiselizumab for advanced gastric and GEJ cancers, and key 2024 breast cancer breakthroughs are reviewed. Experts provide perspective on ...

More research is needed to refine treatment strategies and identify predictive biomarkers for patient selection, according to researchers.